Journal for ImmunoTherapy of Cancer (Nov 2021)
215 Tissue-resident natural killer cells resembling intraepithelial ILC1 have potent anti-tumor activity in human head and neck cancer and represent a novel class of effector cells for immunotherapy
Abstract
No abstracts available.